Chromatin and aberrant enhancer activity in KMT2A rearranged acute lymphoblastic leukemia
Current Opinion in Genetics & Development · 2024
DOI: 10.1016/j.gde.2024.102191 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Opinion in Genetics & Development, 2024. Verfasst von Thomas A Milne. Beteiligte Einrichtung: MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9D…. Hauptthemen laut MEDLINE: Myeloid-Lymphoid Leukemia Protein, Enhancer Elements, Genetic, Histone-Lysine N-Methyltransferase, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, UKRI Medical Research Council.
Abstract (Originalsprache)
To make a multicellular organism, genes need to be transcribed at the right developmental stages and in the right tissues. DNA sequences termed 'enhancers' are crucial to achieve this. Despite concerted efforts, the exact mechanisms of enhancer activity remain elusive. Mixed lineage leukemia (MLL or KMT2A) rearrangements (MLLr), commonly observed in cases of acute lymphoblastic leukemia (ALL) and acute myeloid leukemia, produce novel in-frame fusion proteins. Recent work has shown that the MLL-AF4 fusion protein drives aberrant enhancer activity at key oncogenes in ALL, dependent on the continued presence of MLL-AF4 complex components. As well as providing some general insights into enhancer function, these observations may also provide an explanation for transcriptional heterogeneity observed in MLLr patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- MRC Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK. Electronic address: thomas.milne@imm.ox.ac.uk.
Förderung
- Medical Research Council
- UKRI Medical Research Council
Zitieren
APA
Milne, T. A. (2024). Chromatin and aberrant enhancer activity in KMT2A rearranged acute lymphoblastic leukemia. Current Opinion in Genetics & Development. https://doi.org/10.1016/j.gde.2024.102191
Vancouver
Milne TA. Chromatin and aberrant enhancer activity in KMT2A rearranged acute lymphoblastic leukemia. Current Opinion in Genetics & Development. 2024. doi:10.1016/j.gde.2024.102191
BibTeX
@article{Milne2024,
author = {Milne, Thomas A},
title = {Chromatin and aberrant enhancer activity in KMT2A rearranged acute lymphoblastic leukemia},
journal = {Current Opinion in Genetics & Development},
year = {2024},
doi = {10.1016/j.gde.2024.102191}
}
EUVIMED